Testing effectiveness (Phase 2)UnknownNCT02779101
What this trial is testing
Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)
Who this might be right for
Primary Central Nervous System Lymphoma
Prof. Dr. Matthias Preusser 21